Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-03-03Cross-sectional Evaluation of Psychiatric Population With DELPhI- Characterization of Psychiatric Conditions
-
CLINICAL_TRIALS study record update · 2022-03-02An Open-label Feasibility Trial of Adjunctive Telmisartan in Patients With Treatment Resistant Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-03-02The Effect of Psychoeducation Based on the Transtheoretical Model on Healthy Lifestyle Behaviors in Individuals With Schizophrenia: Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-03-02The Difference of Grey Matter Volume Among the Patients of Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-02-28The Effects of Ginkgo Biloba Extract in the Treatment of Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-02-23Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
-
CLINICAL_TRIALS study record update · 2022-02-18Behavioral Treatment of Drug Abuse in SPMI Patients
-
CLINICAL_TRIALS study record update · 2022-02-16A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Olanzapine Positive Control in Subjects Who Complete Protocols 041021 or 041022.
-
CLINICAL_TRIALS study record update · 2022-02-16Comparison of the Efficacy and Safety of Berberine and Metformin for Schizophrenia Patients With Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2022-02-16Targeting Auditory Hallucinations With Alternating Current Stimulation
-
CLINICAL_TRIALS study record update · 2022-02-16Long-Term Efficacy and Safety Evaluation of Asenapine (10-20 mg/Day) in With Schizophrenia or Schizoaffective Disorder, in a Multicenter Trial Using (10-20 mg/Day) as a Control
-
CLINICAL_TRIALS study record update · 2022-02-14Post-Marketing Surveillance of Safety and Effectiveness of Abilify Maintena® Injections in Korean Patients With Schizophrenia or Bipolar 1 Disorder Under the "New Drug Re-Examination"
-
CLINICAL_TRIALS study record update · 2022-02-11Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia: a Randomized Controlled Multi-centric Study
-
CLINICAL_TRIALS study record update · 2022-02-10The Effect of Individual Psychoeducation Program Based on the Health Promotion Model on the Healthy Living Behaviors of Individuals With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-02-10An Evaluation of Safety, Tolerability and Pharmacokinetics of Single Oral Dose of JX11502MA Capsule on Healthy Human: A Phase Ia, Single Center, Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-02-09A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-02-04An Observational Post-Authorization Safety Surveillance (PASS) Study of Sycrest® (Asenapine) Among Patients Aged 18 and Older Diagnosed With Bipolar Disorder
-
CLINICAL_TRIALS study record update · 2022-02-02Improving Accessibility and Personalization of Cognitive Remediation for Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-02-01Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-01-27Social Cognitive Assessment in Psychiatry - Validation of a New Battery: ClaCoS
-
CLINICAL_TRIALS study record update · 2022-01-26Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-01-20An Open-label Feasibility Trial of Adjunctive L-arginine and Tetrahydrobiopterin Combination in Patients With Treatment Resistant Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-01-14A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Multiple Doses of TPN672 Tablets Maleate in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-01-12IV Ceftriaxone for Refractory Psychosis: a Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-01-11The Efficacy for Execution Function and Genetic Mechanism of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia